Q32 Bio Inc.
QTTB
$5.94
$0.132.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -2.93% | -6.75% | |||
| Gross Profit | -106.38% | 1,518.34% | |||
| SG&A Expenses | -0.86% | 12.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.73% | 3.71% | |||
| Operating Income | -116.83% | 705.50% | |||
| Income Before Tax | -113.18% | 881.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -113.18% | 881.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -113.18% | 881.30% | |||
| EBIT | -116.83% | 705.50% | |||
| EBITDA | -116.60% | 714.07% | |||
| EPS Basic | -111.75% | 861.30% | |||
| Normalized Basic EPS | -114.72% | 707.42% | |||
| EPS Diluted | -111.77% | 860.27% | |||
| Normalized Diluted EPS | -114.76% | 705.99% | |||
| Average Basic Shares Outstanding | 12.20% | 2.64% | |||
| Average Diluted Shares Outstanding | 11.93% | 2.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||